Gene Therapies for Monogenic Autism Spectrum Disorders

Novel genome editing and transient gene therapies have been developed the past ten years, resulting in the first in-human clinical trials for monogenic disorders. Syndromic autism spectrum disorders can be caused by mutations in a single gene. Given the monogenic aspect and severity of syndromic ASD...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Wout Weuring, Jeroen Geerligs, Bobby P. C. Koeleman
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
ASD
Accès en ligne:https://doaj.org/article/36cb1abb0d714d319b1a54ec5f25a48f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!